The prevention, control and treatment of many diseases and conditions remain major challenges within contemporary society. These challenges provide unique opportunities for pharmacologists to discover novel molecular targets for drug action. In this unit of study you will examine six major conditions that affect a range of body systems where improvements in treatment using pharmacotherapies are needed. In learning about unresolved issues, you will also evaluate the complexities of pharmacological treatment, including: ethical considerations, strength of evidence of drug efficacy, as well as safety and tolerability aspects of drug use. Using the tools of pharmacological enquiry you will extend and deepen your practical and cognitive skills through small-group, mentored, laboratory- and problem-based enquiry. In both face-to-face and online learning environments you will explore a range of pharmacotherapeutic options currently available and will have the opportunity to research and apply your knowledge and understanding to unresolved health-related problems. By undertaking this unit you will extend your disciplinary expertise in pharmacology and deepen your skills in critical thinking, problem solving, communication, digital literacy, teamwork and interdisciplinary effectiveness.
Unit details and rules
Academic unit | Pharmacy |
---|---|
Credit points | 6 |
Prerequisites
?
|
An average mark of 70 or above in [(BIOL1XX7 or MBLG1XX1) or (BIOL1XX3 or BIOL1XX8 or MEDS1X01)] and (CHEM1XX1 or CHEM1903). |
Corequisites
?
|
None |
Prohibitions
?
|
PCOL2012 or PCOL2022 or PCOL2555 |
Assumed knowledge
?
|
Fundamentals of pharmacology including pharmacodynamics and pharmacokinetics and molecular pharmacology, for example, as taught in PCOL2011 or PCOL2021 or MEDS2002 or (BMED2401 and BMED2405). |
Available to study abroad and exchange students | Yes |
Teaching staff
Coordinator | Brent McParland, brent.mcparland@sydney.edu.au |
---|